Lupin Shares Gain 2% as Arm Commissions Oncology Block
Shares of Lupin Ltd were trading in the green and 2% higher on 12 November after the subsidiary of the company commissioned an Oncology block. ...
Tag : Lupin
Pharma Stocks Dip up to 2% as Trump Warns of Heavy Drug Import Tariffs
Indian pharmaceutical stocks slipped by up to 2% on Wednesday after US President Donald Trump warned of steep hikes in tariffs on imported medicines, dragging...
Top 10 Pharmaceutical Companies in India in 2025
India’s pharmaceutical industry is on the rise, with its top companies becoming key players on the global stage. Behind their success lies a blend of...
Lupin Has Appointed Abdelaziz Toumi as CEO of Manufacturing Arm
Pharmaceutical major Lupin Limited plans to increase its contract manufacturing business for its international clients and has appointed a new CEO. They have appointed Abdelaziz...
Lupin Shares 7% as Q4 Earnings Failed to Impress Investors
Shares of Lupin crashed 7% on 7 May after the company announced its quarterly earnings for January-March. The drug maker reported a 52% year-on-year increase in...
Lupin Shares Gain 2% on Launching Doxycycline Capsules in US
Shares of Lupin Ltd were trading in the green and 2% higher on 10 April after the company announced launching its first generic version of...
Lupin Gets USFDA Approval for Drug for Gout, Stock Hits Nearly 7-Year High Levels
Lupin’s shares hit a fresh yearly high on January 19 after the pharma company received approval from the United States Food and Drug Administration (US...
Lupin Shares Gain 2% USFDA Approval for Hypertension Drug
Shares of Lupin were trading in the green and 2% higher on 15 January after the company announced receiving approval from the USFDA to market...
Lupin Shares Gain 1% on Launching Cataract Surgery Pain Reduction Drug
Shares of Lupin were trading in the green and 1% higher on 10 January after the company announced the launch of a cataract surgery pain...
Lupin Shares Hit 52-Week High on Receiving USFDA Approval
Shares of Lupin hit a 52-week high of Rs 1,345.75 on 28 December after the company received approval from the USFDA (US Food and Drug...